Journal
NATURE REVIEWS DRUG DISCOVERY
Volume 11, Issue 9, Pages 709-U84Publisher
NATURE PORTFOLIO
DOI: 10.1038/nrd3802
Keywords
-
Funding
- Wellcome Trust
- Wellcome Trust/Medical Research Council
- UK Medical Research Council
- National Institute for Health Research Biomedical Research Unit in Dementia at Addenbrooke's Hospital, Cambridge, UK
- US National Institutes of Health (NIH) [RO1 CA109618, U54AI057156]
- INSERM
- Universite Paris-Sud
- Agence Nationale pour la Recherche
- Institut National du Cancer
- MRC [G0600194, MC_G1000734] Funding Source: UKRI
- Medical Research Council [G0600194, MC_G1000734] Funding Source: researchfish
Ask authors/readers for more resources
Autophagy is an essential, conserved lysosomal degradation pathway that controls the quality of the cytoplasm by eliminating protein aggregates and damaged organelles. It begins when double-membraned autophagosomes engulf portions of the cytoplasm, which is followed by fusion of these vesicles with lysosomes and degradation of the autophagic contents. In addition to its vital homeostatic role, this degradation pathway is involved in various human disorders, including metabolic conditions, neurodegenerative diseases, cancers and infectious diseases. This article provides an overview of the mechanisms and regulation of autophagy, the role of this pathway in disease and strategies for therapeutic modulation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available